Transphorm, Inc. Common Stock
TGAN
TGAN was delisted on the 20th of June, 2024.
39 hedge funds and large institutions have $90.5M invested in Transphorm, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 21 increasing their positions, 9 reducing their positions, and 4 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 9
5% less funds holding
Funds holding: 41 → 39 (-2)
30% less capital invested
Capital invested by funds: $130M → $90.5M (-$39.5M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KKRC
Kohlberg Kravis Roberts & Co
New York
|
+$4.85M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$1.06M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$837K |
| 4 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$578K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$263K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$292K |
| 2 |
SFM
Soros Fund Management
New York
|
-$251K |
| 3 |
AGM
Alpine Global Management
New York
|
-$251K |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$251K |
| 5 |
Millennium Management
New York
|
-$71.1K |
TGAN Hedge Fund Activity: Q3 2023 in Review
39 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Transphorm, Inc. Common Stock (TGAN) for Q3 2023, worth a combined $90.5M — down 30% from $130M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of TGAN and 2 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 21 added.
The largest buyer was Kohlberg Kravis Roberts & Co, adding an estimated $4.85M. The largest seller was JP Morgan Chase, cutting an estimated $292K.
- 39 institutional investors held Transphorm, Inc. Common Stock (TGAN) as of Q3 2023, down from 41 in Q2 2023.
- Funds reported $90.5M of Transphorm, Inc. Common Stock stock for Q3 2023, down 30% quarter-over-quarter.
- 2 funds opened new Transphorm, Inc. Common Stock positions in Q3 2023 and 4 closed out, a net change of -2 holders.
- The largest Transphorm, Inc. Common Stock buyer in Q3 2023 was Kohlberg Kravis Roberts & Co, an estimated $4.85M added.
- The largest Transphorm, Inc. Common Stock seller in Q3 2023 was JP Morgan Chase, an estimated $292K sold.
Based on aggregated 13F filings for Q3 2023.